PP
ELV icon

Patron Partners’s Elevance Health ELV Stock Holding History

Patron Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-743
Closed -$387K – 175
2024
Q3 		$387K Sell
743
-10
-1% -$5.34K 0.21% 113
2024
Q2 		$408K Buy
753
+6
+0.8% +$3.17K 0.24% 112
2024
Q1 		$387K Buy
747
+56
+8% +$27.9K 0.24% 115
2023
Q4 		$326K Buy
691
+47
+7% +$21.7K 0.22% 124
2023
Q3 		$280K Buy
644
+39
+6% +$17.7K 0.21% 122
2023
Q2 		$269K Buy
605
+86
+17% +$39.7K 0.19% 129
2023
Q1 		$239K Buy
519
+21
+4% +$9.99K 0.18% 134
2022
Q4 		$255K Sell
498
-20
-4% -$10.2K 0.19% 128
2022
Q3 		$235K Sell
518
-25
-5% -$12K 0.2% 130
2022
Q2 		$262K Hold
543
– – 0.21% 125
2022
Q1 		$266K Buy
543
+50
+10% +$22.9K 0.18% 131
2021
Q4 		$229K Buy
+493
New +$207K 0.15% 151

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Patron Partners's ELV Position: Q4 2024 in Review

Patron Partners sold out of Elevance Health (ELV) in Q4 2024, closing a stake of 743 shares — an estimated $387K sold.

Patron Partners first reported a position in ELV in Q4 2021 and held it in 12 quarters. The position peaked at $408K in Q2 2024. 1,602 funds tracked by Wall St. Rank hold ELV as of Q4 2024.

  • Patron Partners reported no remaining Elevance Health position as of Q4 2024 after selling out during the quarter.
  • Patron Partners sold 743 Elevance Health shares in Q4 2024, an estimated $387K.
  • Patron Partners first reported a position in Elevance Health in Q4 2021 and held it in 12 quarters.
  • Patron Partners's Elevance Health position peaked at $408K in Q2 2024.
  • 1,602 funds tracked by Wall St. Rank held Elevance Health as of Q4 2024.

Based on Patron Partners's 13F filing for Q4 2024, filed 24 Jan 2025.